Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

Tillmann Cyrus, Joseph L. Witztum, Daniel J. Rader, Rajendra Tangirala, Sergio Fazio, MacRae F. Linton, Colin D. Funk

Research output: Contribution to journalArticle

431 Citations (Scopus)

Abstract

Atherosclerosis may be viewed as an inflammatory disease process that includes early oxidative modification of LDLs, leading to foam cell formation. This 'oxidation hypothesis' has gained general acceptance in recent years, and evidence for the role of lipoxygenases in initiation of, or participation in, the oxidative process is accumulating. However, the relative contribution of macrophage-expressed lipoxygenases to atherogenesis in vivo remains unknown. Here, we provide in vivo evidence for the role of 12/15-lipoxygenase in atherogenesis and demonstrate diminished plasma IgG autoantibodies to oxidized LDL epitopes in 12/15-lipoxygenase knockout mice crossbred with atherosclerosis-prone apo E-deficient mice (apo E(-/-)/L- 12LO(-/-)). In chow-fed 15-week-old apo E(-/-)/L-12LO(-/-) mice, the extent of lesions in whole-aorta en face preparations (198 ± 60 μm2) was strongly reduced (P <0.001, n = 12) when compared with 12/15-lipoxygenase-expressing controls (apo E(-/-)/L-12LO(+/+)), which showed areas of lipid deposition (15,700 ± 2,688 μm2) in the lesser curvature of the aortic arch, branch points, and in the abdominal aorta. These results were observed despite cholesterol, triglyceride, and lipoprotein levels that were similar to those in apo E-deficient mice. Evidence for reduced lesion development was observed even at 1 year of age in apo E(-/-)/L-12LO(-/-) mice. The combined data indicate a role for 12/15-lipoxygenase in the pathogenesis of atherosclerosis and suggest that inhibition of this enzyme may decrease disease progression.

Original languageEnglish (US)
Pages (from-to)1597-1604
Number of pages8
JournalJournal of Clinical Investigation
Volume103
Issue number11
StatePublished - Jun 1999
Externally publishedYes

Fingerprint

Apolipoproteins E
Atherosclerosis
Lipoxygenases
Genes
Foam Cells
Abdominal Aorta
Thoracic Aorta
Knockout Mice
Autoantibodies
Aorta
Disease Progression
12-15-lipoxygenase
Epitopes
Triglycerides
Immunoglobulin G
Macrophages
Lipids
Enzymes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999). Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. Journal of Clinical Investigation, 103(11), 1597-1604.

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. / Cyrus, Tillmann; Witztum, Joseph L.; Rader, Daniel J.; Tangirala, Rajendra; Fazio, Sergio; Linton, MacRae F.; Funk, Colin D.

In: Journal of Clinical Investigation, Vol. 103, No. 11, 06.1999, p. 1597-1604.

Research output: Contribution to journalArticle

Cyrus, T, Witztum, JL, Rader, DJ, Tangirala, R, Fazio, S, Linton, MF & Funk, CD 1999, 'Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice', Journal of Clinical Investigation, vol. 103, no. 11, pp. 1597-1604.
Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF et al. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. Journal of Clinical Investigation. 1999 Jun;103(11):1597-1604.
Cyrus, Tillmann ; Witztum, Joseph L. ; Rader, Daniel J. ; Tangirala, Rajendra ; Fazio, Sergio ; Linton, MacRae F. ; Funk, Colin D. / Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. In: Journal of Clinical Investigation. 1999 ; Vol. 103, No. 11. pp. 1597-1604.
@article{51ae87304b124c71ba22736d43814196,
title = "Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice",
abstract = "Atherosclerosis may be viewed as an inflammatory disease process that includes early oxidative modification of LDLs, leading to foam cell formation. This 'oxidation hypothesis' has gained general acceptance in recent years, and evidence for the role of lipoxygenases in initiation of, or participation in, the oxidative process is accumulating. However, the relative contribution of macrophage-expressed lipoxygenases to atherogenesis in vivo remains unknown. Here, we provide in vivo evidence for the role of 12/15-lipoxygenase in atherogenesis and demonstrate diminished plasma IgG autoantibodies to oxidized LDL epitopes in 12/15-lipoxygenase knockout mice crossbred with atherosclerosis-prone apo E-deficient mice (apo E(-/-)/L- 12LO(-/-)). In chow-fed 15-week-old apo E(-/-)/L-12LO(-/-) mice, the extent of lesions in whole-aorta en face preparations (198 ± 60 μm2) was strongly reduced (P <0.001, n = 12) when compared with 12/15-lipoxygenase-expressing controls (apo E(-/-)/L-12LO(+/+)), which showed areas of lipid deposition (15,700 ± 2,688 μm2) in the lesser curvature of the aortic arch, branch points, and in the abdominal aorta. These results were observed despite cholesterol, triglyceride, and lipoprotein levels that were similar to those in apo E-deficient mice. Evidence for reduced lesion development was observed even at 1 year of age in apo E(-/-)/L-12LO(-/-) mice. The combined data indicate a role for 12/15-lipoxygenase in the pathogenesis of atherosclerosis and suggest that inhibition of this enzyme may decrease disease progression.",
author = "Tillmann Cyrus and Witztum, {Joseph L.} and Rader, {Daniel J.} and Rajendra Tangirala and Sergio Fazio and Linton, {MacRae F.} and Funk, {Colin D.}",
year = "1999",
month = "6",
language = "English (US)",
volume = "103",
pages = "1597--1604",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "11",

}

TY - JOUR

T1 - Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice

AU - Cyrus, Tillmann

AU - Witztum, Joseph L.

AU - Rader, Daniel J.

AU - Tangirala, Rajendra

AU - Fazio, Sergio

AU - Linton, MacRae F.

AU - Funk, Colin D.

PY - 1999/6

Y1 - 1999/6

N2 - Atherosclerosis may be viewed as an inflammatory disease process that includes early oxidative modification of LDLs, leading to foam cell formation. This 'oxidation hypothesis' has gained general acceptance in recent years, and evidence for the role of lipoxygenases in initiation of, or participation in, the oxidative process is accumulating. However, the relative contribution of macrophage-expressed lipoxygenases to atherogenesis in vivo remains unknown. Here, we provide in vivo evidence for the role of 12/15-lipoxygenase in atherogenesis and demonstrate diminished plasma IgG autoantibodies to oxidized LDL epitopes in 12/15-lipoxygenase knockout mice crossbred with atherosclerosis-prone apo E-deficient mice (apo E(-/-)/L- 12LO(-/-)). In chow-fed 15-week-old apo E(-/-)/L-12LO(-/-) mice, the extent of lesions in whole-aorta en face preparations (198 ± 60 μm2) was strongly reduced (P <0.001, n = 12) when compared with 12/15-lipoxygenase-expressing controls (apo E(-/-)/L-12LO(+/+)), which showed areas of lipid deposition (15,700 ± 2,688 μm2) in the lesser curvature of the aortic arch, branch points, and in the abdominal aorta. These results were observed despite cholesterol, triglyceride, and lipoprotein levels that were similar to those in apo E-deficient mice. Evidence for reduced lesion development was observed even at 1 year of age in apo E(-/-)/L-12LO(-/-) mice. The combined data indicate a role for 12/15-lipoxygenase in the pathogenesis of atherosclerosis and suggest that inhibition of this enzyme may decrease disease progression.

AB - Atherosclerosis may be viewed as an inflammatory disease process that includes early oxidative modification of LDLs, leading to foam cell formation. This 'oxidation hypothesis' has gained general acceptance in recent years, and evidence for the role of lipoxygenases in initiation of, or participation in, the oxidative process is accumulating. However, the relative contribution of macrophage-expressed lipoxygenases to atherogenesis in vivo remains unknown. Here, we provide in vivo evidence for the role of 12/15-lipoxygenase in atherogenesis and demonstrate diminished plasma IgG autoantibodies to oxidized LDL epitopes in 12/15-lipoxygenase knockout mice crossbred with atherosclerosis-prone apo E-deficient mice (apo E(-/-)/L- 12LO(-/-)). In chow-fed 15-week-old apo E(-/-)/L-12LO(-/-) mice, the extent of lesions in whole-aorta en face preparations (198 ± 60 μm2) was strongly reduced (P <0.001, n = 12) when compared with 12/15-lipoxygenase-expressing controls (apo E(-/-)/L-12LO(+/+)), which showed areas of lipid deposition (15,700 ± 2,688 μm2) in the lesser curvature of the aortic arch, branch points, and in the abdominal aorta. These results were observed despite cholesterol, triglyceride, and lipoprotein levels that were similar to those in apo E-deficient mice. Evidence for reduced lesion development was observed even at 1 year of age in apo E(-/-)/L-12LO(-/-) mice. The combined data indicate a role for 12/15-lipoxygenase in the pathogenesis of atherosclerosis and suggest that inhibition of this enzyme may decrease disease progression.

UR - http://www.scopus.com/inward/record.url?scp=0032752579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032752579&partnerID=8YFLogxK

M3 - Article

C2 - 10359569

AN - SCOPUS:0032752579

VL - 103

SP - 1597

EP - 1604

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 11

ER -